Centene reported first quarter 2025 diluted EPS of $2.63 and adjusted diluted EPS of $2.90, representing a 28% increase from $2.26 in the first quarter of 2024.

Premium and service revenue grew 17% year-over-year. Membership rose by 29% in Marketplace plans and 22% in Medicare Prescription Drug Plans (PDP) compared to the prior year period. The company raised its 2025 premium and service revenue guidance by $6.0 billion, citing strong Marketplace enrollment and better-than-expected Medicare member retention.

Centene's SilverSummit Healthplan Wins Expanded Nevada Medicaid Contract, Adds Public Option Role

Centene Corporation announced that its subsidiary SilverSummit Healthplan has been awarded a new five-year Nevada Medicaid managed care contract, now expanding into rural and frontier areas previously served via fee-for-service. Starting January 1, 2026, SilverSummit will continue delivering primary care, behavioral health, pharmacy, and telehealth services to over 100,000 Medicaid members. Additionally, SilverSummit’s marketplace offering, Ambetter, was selected for Nevada’s new Battle Born State Plan public option, projected to serve 16,000 individuals in its first year. Both contracts include optional two-year extensions.

Ohana Health Plan and HMHB Hawaii Expand Maternal Health Program with $300,000 Investment

On March 27, 2025, ‘Ohana Health Plan, a Centene Corporation company, announced a $300,000 investment to expand its partnership with the Healthy Mothers Healthy Babies Coalition of Hawaii (HMHB Hawaii). This brings their total capital investment in the "Mana ‘Ohana" program to $500,000.

Mana ‘Ohana is a holistic maternal and child health program led by midwives and rooted in culturally responsive, community-based care. It provides ‘Ohana Health Plan members with perinatal support services—both clinical and social—delivered directly to communities through mobile clinics.

The program has already demonstrated impact, with more than 40% of the plan’s pregnant members utilizing its services in the first year. According to Kari Shintaku, Vice President of Population Health and Quality Improvement at ‘Ohana Health Plan, this led to improved prenatal and postpartum care and a reduction in NICU costs.

Sunny Chen, CEO of HMHB Hawaii, highlighted the importance of the partnership, noting that Mana ‘Ohana is expanding access to care that is both culturally sensitive and person-centered, improving outcomes for mothers and babies across Hawaii.

The initiative exemplifies the power of strategic, locally tailored partnerships in improving public health outcomes.

'Ohana Health Plan, a leading provider of government-sponsored managed care services in Hawaiʻi and a Centene Corporation company (NYSE: CNC), announced today a $25,000 contribution to the University of Hawaii Foundation for the 'Ohana Health Plan Pre-Nursing Scholarship at the University of Hawaiʻi West Oʻahu.

Centene Corporation announced that its subsidiary, Meridian Health Plan of Illinois, has been awarded a contract by the Illinois Department of Healthcare and Family Services to continue providing services for dually eligible Medicare and Medicaid members through a Fully Integrated Dual Eligible Special Needs Plan (D-SNP). The contract, beginning January 1, 2026, and running through December 31, 2029, includes an option for renewal for up to 10 years.

Meridian will serve 77,000 dually eligible individuals across Illinois, expanding to 60,000 additional Managed Long Term Services and Supports members in 2027. The plan will focus on integrating medical, behavioral, and social care to improve health outcomes and reduce disparities.

Centene CEO Sarah M. London emphasized the company’s commitment to addressing the unique healthcare needs of dually eligible individuals. Meridian has served Illinois since 2008 and is one of four health plans selected for the program.

Centene, a Fortune 500 company, provides government-sponsored healthcare programs, including Medicaid and Medicare, to more than one in 15 individuals nationwide. The company focuses on accessible, high-quality, and cost-effective healthcare solutions.

Centene Corporation Enters Into New $6 Billion Credit Agreement
St. Louis, Missouri – March 5, 2025 – Centene Corporation (NYSE: CNC), a leading multinational healthcare enterprise, announced today that it has entered into a new $6 billion credit agreement (the New Credit Agreement) with Wells Fargo Bank, National Association as administrative agent, and a syndicate of lenders. This agreement replaces the Fourth Amended and Restated Credit Agreement from August 16, 2021, which has now been terminated.

Key Terms of the New Credit Agreement
The New Credit Agreement consists of:

$4 billion revolving credit facility
$2 billion term loan facility
Maturity Date: March 5, 2030
Loans can be denominated in various currencies, including U.S. dollars, Euros, Sterling, Swiss Francs, Yen, Australian dollars, and Canadian dollars
Interest rates are determined based on benchmark rates applicable to the currency borrowed, plus an applicable margin tied to Centene’s credit rating from S&P and Moody’s
Debt Covenant and Usage of Proceeds
Debt-to-capital ratio must not exceed 0.60 to 1.00, with a temporary increase to 0.65 to 1.00 allowed for a limited time following a material acquisition
Centene used an initial drawing from the Term Loan Facility to:
Refinance existing indebtedness, including obligations under the previous credit agreement
Fund general corporate purposes and working capital needs
Pay transaction-related fees
Additional Terms and Conditions
Prepayments & Reductions: Voluntary prepayments and reductions of unused commitments are permitted without penalty
Events of Default: The credit facility is subject to acceleration upon certain events, including:
Cross-defaults on Centene’s debts exceeding $500 million
Judgments/orders of $500 million or more that are unpaid or unstayed
Change in control of Centene
Failure to make payments when due
Bankruptcy or insolvency events
The New Credit Agreement strengthens Centene’s financial flexibility, providing enhanced liquidity and strategic funding capacity as the company continues its growth and operational improvements.

About Centene Corporation
Centene Corporation (NYSE: CNC) is a leading healthcare enterprise that provides government-sponsored healthcare programs focusing on underinsured and uninsured individuals. It offers a diverse portfolio of services including Medicaid, Medicare, and Health Insurance Marketplace coverage.

Peach State Health Plan and the Centene Foundation announced an investment in the redevelopment of Atlanta’s Bowen Homes community, partnering with Atlanta Housing and the City of Atlanta. This initiative, led by McCormack Baron Salazar, aims to provide quality housing and healthcare while addressing health disparities. The project will include over 750 residential units with community-focused amenities. The Centene Foundation’s funding is part of a broader commitment to improving healthcare access and addressing social determinants of health. Peach State Health Plan serves Medicaid and uninsured populations, while the Centene Foundation focuses on healthcare access, social services, and education in underserved communities.

Centene Corporation announced that its senior management team will meet with investors on March 4, 2025, and reaffirm its 2025 full-year adjusted diluted earnings per share (EPS) guidance floor of greater than $7.25. This guidance was initially provided on February 4, 2025.

The company uses non-GAAP financial measures to help investors assess its core operations consistently across periods. These measures exclude amortization of acquired intangible assets, acquisition and divestiture-related expenses, and other items. Centene emphasizes that its non-GAAP financial measures may differ from those used by other companies and should not be viewed as a substitute for GAAP financial data.

The company also issued forward-looking statements regarding its financial and operational performance, regulatory changes, contract developments, and market conditions. These statements are subject to various risks, including competition, government reimbursement rates, changes in healthcare laws, cybersecurity threats, and economic factors.

Centene advises investors that its guidance remains effective only as of the date issued and will not be updated unless publicly reaffirmed.